Publication Name	World Journal of Clinical Cases
Manuscript ID	68251
Country	Egypt

Received	2021-05-16 18:11
Peer-Review Started	2021-05-16 18:14
To Make the First Decision
Return for Revision	2021-07-28 02:27
Revised	2021-08-05 02:32
Second Decision	2022-01-25 03:47
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2022-01-26 22:17
Articles in Press	2022-01-26 22:17
Publication Fee Transferred
Edit the Manuscript by Language Editor	2022-01-12 06:20
Typeset the Manuscript	2022-02-15 07:51
Publish the Manuscript Online	2022-02-23 15:51

ISSN	2307-8960 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Minireviews
Article Title	Association between direct-acting antiviral agents in hepatitis C virus treatment and hepatocellular carcinoma occurrence and recurrence: The endless debate
Manuscript Source	Invited Manuscript
All Author List	Ahmed Kamal, Ahmed Elsheaita and Mahmoud Abdelnabi
ORCID	Author(s) ORCID Number Ahmed Kamal http://orcid.org/0000-0003-0957-0977 Ahmed Elsheaita http://orcid.org/0000-0003-3323-6311 Mahmoud Abdelnabi http://orcid.org/0000-0001-8016-9049
Funding Agency and Grant Number
Corresponding Author	Mahmoud Abdelnabi, MD, MSc, Internal Medicine Department, Texas Tech University Health Science Center, 3601 4th St, Lubbock, TX 79430, United States. mahmoud.hassan.abdelnabi@outlook.com
Key Words	Hepatitis C virus; Sustained virologic response; Direct-acting antiviral drugs; Hepatocellular carcinoma; Liver cirrhosis
Core Tip	Present evidence does not confirm or repudiate a higher rate of de novo HCC occurrence or recurrence related to direct-acting antiviral agent (DAA) therapy. More trials are required to determine whether there is an association between HCC occurrence or recurrence and DAA or if it is mainly related to preexisting liver cirrhosis.
Publish Date	2022-02-23 15:51
Citation	Kamal A, Elsheaita A, Abdelnabi M. Association between direct-acting antiviral agents in hepatitis C virus treatment and hepatocellular carcinoma occurrence and recurrence: The endless debate. World J Clin Cases 2022; 10(6): 1764-1774
URL	https://www.wjgnet.com/2307-8960/full/v10/i6/1764.htm
DOI	https://dx.doi.org/10.12998/wjcc.v10.i6.1764

Full Article (PDF)	WJCC-10-1764.pdf
Full Article (Word)	WJCC-10-1764.docx
Manuscript File	68251_Auto_Edited-CKL-Filipodia.docx
Answering Reviewers	68251-Answering reviewers.pdf
Audio Core Tip	68251-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	68251-Conflict-of-interest statement.pdf
Copyright License Agreement	68251-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	68251-Language certificate.pdf
Peer-review Report	68251-Peer-review(s).pdf
Scientific Misconduct Check	68251-Bing-Chang KL-2.jpg
Scientific Misconduct Check	68251-Bing-Wang JL-1.jpg
Scientific Editor Work List	68251-Scientific editor work list.pdf